Recent studies further support this, showing that FOLH1 (PSMA-encoding gene) expression is associated with tumor angiogenesis and predicts progression-free survival in metastatic ccRCC (m-ccRCC) patients treated with VEGF inhibitors (VEGFi) [39]. Here, VEGFA is linked to nonpapillary renal cell carcinoma.